Imperial Innovations (IVO)
market vs.
industry GROWTH & VALUE
| 12m Forecast Rolling | ||||
| PE Ratio (f) | 170 |
|
|
|
| PEG Ratio (f) |
|
|
||
| EPS Growth (f) | % |
|
|
|
| Dividend Yield (f) | % |
|
|
|
| Valuation (ttm) | ||||
| Price to Book Value | 1.24 |
|
|
|
| Price to Tang. Book |
|
|
||
| Price to Free Cashflow |
|
|
||
| Price to Sales |
|
|
||
| EV to EBITDA |
|
|
||
market vs.
industry QUALITY
| Year End 31st Jul | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | TTM | 2013E | 2014E | CAGR / Avg | |
| Revenue | £m | ||||||||||
| Operating Profit | £m | ||||||||||
| Net Profit | £m | ||||||||||
| EPS Reported | p | ||||||||||
| EPS Normalised | p | ||||||||||
| EPS Growth | % | ||||||||||
| PE Ratio | x | ||||||||||
| PEG | x | ||||||||||
| Profitability | |||||||||||
| Operating Margin | % | ||||||||||
| ROA | % | ||||||||||
| ROCE | % | ||||||||||
| ROE | % | ||||||||||
| Cashflow | |||||||||||
| Op. Cashflow ps | p | ||||||||||
| Capex ps | p | ||||||||||
| Free Cashflow ps | p | ||||||||||
| Dividends | |||||||||||
| Dividend ps | p | ||||||||||
| Dividend Growth | % | ||||||||||
| Dividend Yield | % | ||||||||||
| Dividend Cover | x | ||||||||||
| Balance Sheet | |||||||||||
| Cash etc | £m | ||||||||||
| Working Capital | £m | ||||||||||
| Net Fixed Assets | £m | ||||||||||
| Net Debt | £m | ||||||||||
| Book Value | £m | ||||||||||
| Average Shares | m | ||||||||||
| Book Value ps | p | +20.9% | |||||||||
FINANCIAL BRIEF: For the six months ended 31 January 2013, Imperial Innovations Group plc revenues remained flat at L1.6M. Net income decreased 1% to L921K. Revenues reflect market conditions. Net income was partially offset by Finance income decrease of 40% to L771K (income). Basic Earnings per Share excluding Extraordinary Items remained flat at L0.01. more »
| Leverage (ttm) | Total | Ex Intang | |||
| Gross Gearing | % | ||||
| Net Gearing | % | ||||
| Cash / Assets | % | ||||
| Liquidity (ttm) | ||
| Current Ratio | ||
| Quick Ratio | ||
| Interest Cover | ||
| Efficiency (ttm) | ||
| Asset Turnover | ||
| Rec's Turnover | ||
| Stock Turnover | ||
market vs.
industry RECENT HISTORY
| Latest interim period (ended 31st Jan '13) vs. prior year | ||||
| Sales Growth | % |
|
|
|
| EPS Growth | % |
|
|
|
| 3yr Average Annualised | ||||
| Sales Growth | % |
|
|
|
| EPS Growth | % |
|
|
|
| DPS Growth | % |
|
|
|
BROKER CONSENSUS & FORECAST TREND
| Recommendation: | Strong Sell | Sell | Hold | Buy | Strong Buy |
|---|---|---|---|---|---|
| No. of Analysts: | 0 | 0 | 1 | 1 | 0 |
Imperial Innovations is a United Kingdom-based firm that combines the activities of technology transfer, company incubation and investment. The Firm sources and assesses technologies from Imperial College London then advises on how to protect inventions and develop an appropriate IP protection strategy. It carries out market research to identify the product and market opportunity, assessing market need and the competition. It constructs a proof of concept strategy to demonstrate the performance and commercial potential of the technology. Then it determines the right commercialization strategy for a new technology. The Firm forms new companies and recruit experienced entrepreneurs to run them. The Firm also monitors its companies closely and guides them as they prepare for investment. It also invests in businesses either leading or co-investing in investment rounds.
Directors: Susan Searle (CEO) 49, Anjum Ahmed (Fin. Dir.) , Russ Cummings (Chief Inv.Off.) 48, Justin Bowen (Counsel) 42, Tony Hickson (Mgng.Dir.) , Nigel Pitchford (Mgng.Dir.) , Robert Bahns (Other) , Maina Bhaman (Other) , Jon Edington (Other) , Brian Graves (Other) ,
No. of Employees: 56 No. of Shareholders: n/a
| Last Annual | July 31st, 2012 |
| Last Interim | January 31st, 2013 |
| Shares in Issue | 99,651,035 |
| Free Float | 68.5m (68.7%) |
| Sector | Industrials |
| Industry | Professional & Commercial Services |
| Index | |
| Exchange |
London Stock Exchange (AIM) |
| Eligible for | an ISA? a SIPP? |
| Address | 52 Princes GateExhibition Road, LONDON, SW7 2PG, United Kingdom |
| Web | http://www.imperialinnovations.co.uk |
| Phone | +44 20 75814949 |
| Contact | Susan Searle (Chief Executive Officer, Executive Director) |
| Registrar | Lloyds TSB Registrars (London) |
| Auditors | PricewaterhouseCoopers LLP |
| 8th May | Cell Medica treats first patient in new trial |
| 29th Apr | Investment team appointment |
| 17th Apr | Board change |
| 22nd Mar | Half year results |
| 1st Mar | Notice of Results |
| 1st Mar | Notification of major interest in shares |
Recent ↓
